PREVAIL OVER CANCER
LIVE

Serial Number

88709216

Owner

EXELIXIS, INC.

Attorney

Anessa Kramer

First Use Date

Aug 13, 2020

Filing Date

Nov 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PREVAIL OVER CANCER Trademark

Serial Number: 88709216 • Registration: 6212692

PREVAIL OVER CANCER is a trademark filed by EXELIXIS, INC. on November 27, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EXELIXIS, INC. (58 trademarks)

170 HARBOR WAY
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 03

Trademark Details

Filing Date

November 27, 2019

Registration Date

December 1, 2020

First Use Anywhere

August 13, 2020

First Use in Commerce

August 13, 2020

Published for Opposition

April 7, 2020

Goods & Services

Online information services, namely, providing scientific research information related to oncological diseases

Medical information services, namely, providing information on pharmaceutical products in the field of oncology; online information services, namely, providing medical information related to oncological diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 28, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 27, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 17, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 17, 2020 AITU
USE AMENDMENT FILED
Oct 1, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 1, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2020 CNSA
ASSIGNED TO EXAMINER
Mar 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2019 NWOS
NEW APPLICATION ENTERED
Nov 30, 2019 NWAP